Serveur d'exploration sur le Covid à Stanford

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Risk of pre-term births and major birth defects resulting from paternal intake of COVID-19 medications prior to conception.

Identifieur interne : 000304 ( Main/Exploration ); précédent : 000303; suivant : 000305

Risk of pre-term births and major birth defects resulting from paternal intake of COVID-19 medications prior to conception.

Auteurs : Silvia Rizzi [Danemark] ; Maarten J. Wensink [Danemark] ; Rune Lindahl-Jacobsen [Danemark] ; Lu Tian [États-Unis] ; Ying Lu [États-Unis] ; Michael L. Eisenberg [États-Unis]

Source :

RBID : pubmed:33160408

Descripteurs français

English descriptors

Abstract

OBJECTIVE

With the ongoing COVID-19 pandemic, large numbers of people will receive one of the several medications proposed to treat COVID-19, including patients of reproductive age. Given that some medications have shown adverse effects on sperm quality, there might be a transgenerational concern. We aim at examining the association between drugs proposed to treat COVID-19 when taken by the father around conception and any pre-term birth or major birth defects in offspring in a nation-wide cohort study using Danish registry data. Offspring whose father filled at least one prescription of the following medications in the 3 months preceding conception were considered exposed: chloroquine, hydroxychloroquine, losartan, azithromycin, naproxen, dexamethasone and prednisone.

RESULTS

For azithromycin and naproxen, large numbers of offspring were exposed (> 1800 offspring), and we found no association with adverse birth outcomes. For chloroquine, losartan and dexamethasone, exposure was intermediate (~ 900 offspring), and there was no statistically significant association with birth defects. For hydroxychloroquine and prednisone, exposure was limited (< 300 offspring). Our evidence suggests that azithromycin and naproxen are safe with respect to pre-term birth and birth defects. For the other drugs investigated larger exposures are needed for conclusive statements.


DOI: 10.1186/s13104-020-05358-x
PubMed: 33160408
PubMed Central: PMC7647878


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Risk of pre-term births and major birth defects resulting from paternal intake of COVID-19 medications prior to conception.</title>
<author>
<name sortKey="Rizzi, Silvia" sort="Rizzi, Silvia" uniqKey="Rizzi S" first="Silvia" last="Rizzi">Silvia Rizzi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Epidemiology, Biostatistics and Biodemography, University of Southern Denmark, Odense, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Epidemiology, Biostatistics and Biodemography, University of Southern Denmark, Odense</wicri:regionArea>
<wicri:noRegion>Odense</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense</wicri:regionArea>
<wicri:noRegion>Odense</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wensink, Maarten J" sort="Wensink, Maarten J" uniqKey="Wensink M" first="Maarten J" last="Wensink">Maarten J. Wensink</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Epidemiology, Biostatistics and Biodemography, University of Southern Denmark, Odense, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Epidemiology, Biostatistics and Biodemography, University of Southern Denmark, Odense</wicri:regionArea>
<wicri:noRegion>Odense</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense</wicri:regionArea>
<wicri:noRegion>Odense</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lindahl Jacobsen, Rune" sort="Lindahl Jacobsen, Rune" uniqKey="Lindahl Jacobsen R" first="Rune" last="Lindahl-Jacobsen">Rune Lindahl-Jacobsen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Epidemiology, Biostatistics and Biodemography, University of Southern Denmark, Odense, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Epidemiology, Biostatistics and Biodemography, University of Southern Denmark, Odense</wicri:regionArea>
<wicri:noRegion>Odense</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense</wicri:regionArea>
<wicri:noRegion>Odense</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tian, Lu" sort="Tian, Lu" uniqKey="Tian L" first="Lu" last="Tian">Lu Tian</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biomedical Data Science, Stanford University School of Medicine, Stanford</wicri:regionArea>
<placeName>
<settlement type="city">Stanford (Californie)</settlement>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lu, Ying" sort="Lu, Ying" uniqKey="Lu Y" first="Ying" last="Lu">Ying Lu</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biomedical Data Science, Stanford University School of Medicine, Stanford</wicri:regionArea>
<placeName>
<settlement type="city">Stanford (Californie)</settlement>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Eisenberg, Michael L" sort="Eisenberg, Michael L" uniqKey="Eisenberg M" first="Michael L" last="Eisenberg">Michael L. Eisenberg</name>
<affiliation wicri:level="2">
<nlm:affiliation>Male Reproductive Medicine and Surgery, Department of Urology and Obstetrics & Gynecology, Stanford University School of Medicine, 300 Pasteur Drive, S-287, Stanford, CA, USA. meisenb@stanford.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Male Reproductive Medicine and Surgery, Department of Urology and Obstetrics & Gynecology, Stanford University School of Medicine, 300 Pasteur Drive, S-287, Stanford, CA</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33160408</idno>
<idno type="pmid">33160408</idno>
<idno type="doi">10.1186/s13104-020-05358-x</idno>
<idno type="pmc">PMC7647878</idno>
<idno type="wicri:Area/Main/Corpus">000180</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000180</idno>
<idno type="wicri:Area/Main/Curation">000180</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000180</idno>
<idno type="wicri:Area/Main/Exploration">000180</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Risk of pre-term births and major birth defects resulting from paternal intake of COVID-19 medications prior to conception.</title>
<author>
<name sortKey="Rizzi, Silvia" sort="Rizzi, Silvia" uniqKey="Rizzi S" first="Silvia" last="Rizzi">Silvia Rizzi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Epidemiology, Biostatistics and Biodemography, University of Southern Denmark, Odense, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Epidemiology, Biostatistics and Biodemography, University of Southern Denmark, Odense</wicri:regionArea>
<wicri:noRegion>Odense</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense</wicri:regionArea>
<wicri:noRegion>Odense</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wensink, Maarten J" sort="Wensink, Maarten J" uniqKey="Wensink M" first="Maarten J" last="Wensink">Maarten J. Wensink</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Epidemiology, Biostatistics and Biodemography, University of Southern Denmark, Odense, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Epidemiology, Biostatistics and Biodemography, University of Southern Denmark, Odense</wicri:regionArea>
<wicri:noRegion>Odense</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense</wicri:regionArea>
<wicri:noRegion>Odense</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lindahl Jacobsen, Rune" sort="Lindahl Jacobsen, Rune" uniqKey="Lindahl Jacobsen R" first="Rune" last="Lindahl-Jacobsen">Rune Lindahl-Jacobsen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Epidemiology, Biostatistics and Biodemography, University of Southern Denmark, Odense, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Epidemiology, Biostatistics and Biodemography, University of Southern Denmark, Odense</wicri:regionArea>
<wicri:noRegion>Odense</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense</wicri:regionArea>
<wicri:noRegion>Odense</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tian, Lu" sort="Tian, Lu" uniqKey="Tian L" first="Lu" last="Tian">Lu Tian</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biomedical Data Science, Stanford University School of Medicine, Stanford</wicri:regionArea>
<placeName>
<settlement type="city">Stanford (Californie)</settlement>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lu, Ying" sort="Lu, Ying" uniqKey="Lu Y" first="Ying" last="Lu">Ying Lu</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biomedical Data Science, Stanford University School of Medicine, Stanford</wicri:regionArea>
<placeName>
<settlement type="city">Stanford (Californie)</settlement>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Eisenberg, Michael L" sort="Eisenberg, Michael L" uniqKey="Eisenberg M" first="Michael L" last="Eisenberg">Michael L. Eisenberg</name>
<affiliation wicri:level="2">
<nlm:affiliation>Male Reproductive Medicine and Surgery, Department of Urology and Obstetrics & Gynecology, Stanford University School of Medicine, 300 Pasteur Drive, S-287, Stanford, CA, USA. meisenb@stanford.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Male Reproductive Medicine and Surgery, Department of Urology and Obstetrics & Gynecology, Stanford University School of Medicine, 300 Pasteur Drive, S-287, Stanford, CA</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">BMC research notes</title>
<idno type="eISSN">1756-0500</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Abnormalities, Drug-Induced (epidemiology)</term>
<term>Abnormalities, Drug-Induced (etiology)</term>
<term>Adult (MeSH)</term>
<term>Antiviral Agents (adverse effects)</term>
<term>COVID-19 (MeSH)</term>
<term>Cohort Studies (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Denmark (MeSH)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Paternal Exposure (MeSH)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Premature Birth (chemically induced)</term>
<term>Risk Assessment (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte (MeSH)</term>
<term>Antiviraux (effets indésirables)</term>
<term>Appréciation des risques (MeSH)</term>
<term>Danemark (MeSH)</term>
<term>Exposition paternelle (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Malformations dues aux médicaments et aux drogues (épidémiologie)</term>
<term>Malformations dues aux médicaments et aux drogues (étiologie)</term>
<term>Mâle (MeSH)</term>
<term>Naissance prématurée (induit chimiquement)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Études de cohortes (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Denmark</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en">
<term>Premature Birth</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Abnormalities, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Abnormalities, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" qualifier="induit chimiquement" xml:lang="fr">
<term>Naissance prématurée</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Malformations dues aux médicaments et aux drogues</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Malformations dues aux médicaments et aux drogues</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>COVID-19</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Pandemics</term>
<term>Paternal Exposure</term>
<term>Risk Assessment</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Appréciation des risques</term>
<term>Danemark</term>
<term>Exposition paternelle</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Études de cohortes</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Danemark</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>OBJECTIVE</b>
</p>
<p>With the ongoing COVID-19 pandemic, large numbers of people will receive one of the several medications proposed to treat COVID-19, including patients of reproductive age. Given that some medications have shown adverse effects on sperm quality, there might be a transgenerational concern. We aim at examining the association between drugs proposed to treat COVID-19 when taken by the father around conception and any pre-term birth or major birth defects in offspring in a nation-wide cohort study using Danish registry data. Offspring whose father filled at least one prescription of the following medications in the 3 months preceding conception were considered exposed: chloroquine, hydroxychloroquine, losartan, azithromycin, naproxen, dexamethasone and prednisone.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>For azithromycin and naproxen, large numbers of offspring were exposed (> 1800 offspring), and we found no association with adverse birth outcomes. For chloroquine, losartan and dexamethasone, exposure was intermediate (~ 900 offspring), and there was no statistically significant association with birth defects. For hydroxychloroquine and prednisone, exposure was limited (< 300 offspring). Our evidence suggests that azithromycin and naproxen are safe with respect to pre-term birth and birth defects. For the other drugs investigated larger exposures are needed for conclusive statements.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">33160408</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>11</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1756-0500</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>13</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2020</Year>
<Month>Nov</Month>
<Day>07</Day>
</PubDate>
</JournalIssue>
<Title>BMC research notes</Title>
<ISOAbbreviation>BMC Res Notes</ISOAbbreviation>
</Journal>
<ArticleTitle>Risk of pre-term births and major birth defects resulting from paternal intake of COVID-19 medications prior to conception.</ArticleTitle>
<Pagination>
<MedlinePgn>509</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13104-020-05358-x</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">With the ongoing COVID-19 pandemic, large numbers of people will receive one of the several medications proposed to treat COVID-19, including patients of reproductive age. Given that some medications have shown adverse effects on sperm quality, there might be a transgenerational concern. We aim at examining the association between drugs proposed to treat COVID-19 when taken by the father around conception and any pre-term birth or major birth defects in offspring in a nation-wide cohort study using Danish registry data. Offspring whose father filled at least one prescription of the following medications in the 3 months preceding conception were considered exposed: chloroquine, hydroxychloroquine, losartan, azithromycin, naproxen, dexamethasone and prednisone.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">For azithromycin and naproxen, large numbers of offspring were exposed (> 1800 offspring), and we found no association with adverse birth outcomes. For chloroquine, losartan and dexamethasone, exposure was intermediate (~ 900 offspring), and there was no statistically significant association with birth defects. For hydroxychloroquine and prednisone, exposure was limited (< 300 offspring). Our evidence suggests that azithromycin and naproxen are safe with respect to pre-term birth and birth defects. For the other drugs investigated larger exposures are needed for conclusive statements.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rizzi</LastName>
<ForeName>Silvia</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-3512-2361</Identifier>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, Biostatistics and Biodemography, University of Southern Denmark, Odense, Denmark.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wensink</LastName>
<ForeName>Maarten J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, Biostatistics and Biodemography, University of Southern Denmark, Odense, Denmark.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lindahl-Jacobsen</LastName>
<ForeName>Rune</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, Biostatistics and Biodemography, University of Southern Denmark, Odense, Denmark.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tian</LastName>
<ForeName>Lu</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lu</LastName>
<ForeName>Ying</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eisenberg</LastName>
<ForeName>Michael L</ForeName>
<Initials>ML</Initials>
<AffiliationInfo>
<Affiliation>Male Reproductive Medicine and Surgery, Department of Urology and Obstetrics & Gynecology, Stanford University School of Medicine, 300 Pasteur Drive, S-287, Stanford, CA, USA. meisenb@stanford.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>HD096468</GrantID>
<Acronym>NH</Acronym>
<Agency>NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>11</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>BMC Res Notes</MedlineTA>
<NlmUniqueID>101462768</NlmUniqueID>
<ISSNLinking>1756-0500</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="UpdateOf">
<RefSource>Res Sq. 2020 Aug 26;:</RefSource>
<PMID Version="1">32869015</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000014" MajorTopicYN="N">Abnormalities, Drug-Induced</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003718" MajorTopicYN="N" Type="Geographic">Denmark</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018812" MajorTopicYN="Y">Paternal Exposure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D047928" MajorTopicYN="N">Premature Birth</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Congenital malformation</Keyword>
<Keyword MajorTopicYN="N">Paternal reproductive safety</Keyword>
<Keyword MajorTopicYN="N">Pharmacological treatment</Keyword>
<Keyword MajorTopicYN="N">Pre-term birth</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>08</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>10</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>11</Month>
<Day>8</Day>
<Hour>20</Hour>
<Minute>21</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>11</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>11</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">33160408</ArticleId>
<ArticleId IdType="doi">10.1186/s13104-020-05358-x</ArticleId>
<ArticleId IdType="pii">10.1186/s13104-020-05358-x</ArticleId>
<ArticleId IdType="pmc">PMC7647878</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>West Afr J Med. 1993 Apr-Jun;12(2):118-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8398931</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Digit Health. 2020 Jun;2(6):e286-e287</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32363333</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Epidemiol. 2017 Jun 1;46(3):798-798f</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27789670</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Epidemiol. 2018 Jan;33(1):27-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29349587</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Andrologia. 2018 Feb;50(1):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28752572</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Urology. 2014 Apr;83(4):800-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24529582</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Epidemiol. 2015 Nov 17;7:449-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26604824</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Public Health. 2020 Apr 29;8:152</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32411652</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Danemark</li>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
</region>
<settlement>
<li>Stanford (Californie)</li>
</settlement>
</list>
<tree>
<country name="Danemark">
<noRegion>
<name sortKey="Rizzi, Silvia" sort="Rizzi, Silvia" uniqKey="Rizzi S" first="Silvia" last="Rizzi">Silvia Rizzi</name>
</noRegion>
<name sortKey="Lindahl Jacobsen, Rune" sort="Lindahl Jacobsen, Rune" uniqKey="Lindahl Jacobsen R" first="Rune" last="Lindahl-Jacobsen">Rune Lindahl-Jacobsen</name>
<name sortKey="Lindahl Jacobsen, Rune" sort="Lindahl Jacobsen, Rune" uniqKey="Lindahl Jacobsen R" first="Rune" last="Lindahl-Jacobsen">Rune Lindahl-Jacobsen</name>
<name sortKey="Rizzi, Silvia" sort="Rizzi, Silvia" uniqKey="Rizzi S" first="Silvia" last="Rizzi">Silvia Rizzi</name>
<name sortKey="Wensink, Maarten J" sort="Wensink, Maarten J" uniqKey="Wensink M" first="Maarten J" last="Wensink">Maarten J. Wensink</name>
<name sortKey="Wensink, Maarten J" sort="Wensink, Maarten J" uniqKey="Wensink M" first="Maarten J" last="Wensink">Maarten J. Wensink</name>
</country>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Tian, Lu" sort="Tian, Lu" uniqKey="Tian L" first="Lu" last="Tian">Lu Tian</name>
</region>
<name sortKey="Eisenberg, Michael L" sort="Eisenberg, Michael L" uniqKey="Eisenberg M" first="Michael L" last="Eisenberg">Michael L. Eisenberg</name>
<name sortKey="Lu, Ying" sort="Lu, Ying" uniqKey="Lu Y" first="Ying" last="Lu">Ying Lu</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidStanfordV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000304 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000304 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidStanfordV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:33160408
   |texte=   Risk of pre-term births and major birth defects resulting from paternal intake of COVID-19 medications prior to conception.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:33160408" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidStanfordV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Tue Feb 2 21:24:25 2021. Site generation: Tue Feb 2 21:26:08 2021